A group of patients joins the patient panel at the 2023 International Symposium on Malignant Mesothelioma to discuss their experiences of diagnosis, finding an expert medical team, treatment, side effects from the cancer and treatment side effects.
This is a recording of a session at the 2023 International Symposium on Malignant Mesothelioma. This symposium is made possible by our generous sponsors: Belluck and Fox, LLP; Maune Raichle Hartley French & Mudd, LLC (MRHFM); Polaris Pharmaceuticals, Inc.; Bristol Myers Squibb; Merck; The Gori Law Firm; Ikena Oncology; Early Lucarelli Sweeney & Meisenkothen; Novacure
Find other recorded sessions and more information at www.curemeso.org/symposium
